<?xml version="1.0" encoding="UTF-8"?>
<ref id="B2">
 <label>2</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jain</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Keating</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Thompson</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Ibrutinib and venetoclax for first-line treatment of CLL</article-title>
  <source>
   <italic toggle="yes">New England Journal of Medicine</italic>
  </source>
  <year>2019</year>
  <volume>380</volume>
  <issue>22</issue>
  <fpage>2095</fpage>
  <lpage>2103</lpage>
  <pub-id pub-id-type="doi">10.1056/nejmoa1900574</pub-id>
  <pub-id pub-id-type="other">2-s2.0-85066459165</pub-id>
  <pub-id pub-id-type="pmid">31141631</pub-id>
 </element-citation>
</ref>
